New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET
09 août 2024 09h30 HE
|
FMW Media Works Corp
New to The Street TV Announces Episode 583, Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024
BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family
30 juil. 2024 07h00 HE
|
BioCardia, Inc.
BioCardia, Inc., today reported it has submitted a 510(k) for approval of its patented Morph® DNA™ Steerable Introducer Sheath with the FDA.
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
18 juin 2024 11h13 HE
|
Truveta
BELLEVUE, Wash., June 18, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug...
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
13 mars 2024 09h00 HE
|
Femasys Inc.
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM ET...
Beam Global Announces New Federal Customers Placed First-Time Orders for EV ARC Solar-Powered EV Charging Systems
13 févr. 2024 06h00 HE
|
Beam Global
Beam Global Announces New Federal Customers Placed First-Time Orders for EV ARC Solar-Powered EV Charging Systems
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
08 févr. 2024 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions...
Robbins LLP Reminds Brainstorm Cell Therapeutics Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Against BCLI
15 déc. 2023 17h36 HE
|
Robbins LLP
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn
New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT
01 déc. 2023 09h30 HE
|
FMW Media Works Corp
New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
14 nov. 2023 07h15 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
KVUE Class Action Notice: Robbins LLP Reminds Informs Investors of Lead Plaintiff Deadline in Kenvue Inc. Securities Fraud Class Action
16 oct. 2023 14h08 HE
|
Robbins LLP
Kenvue Inc. (KVUE) Made False and Misleading Statements in its Registration Statement in Support of its IPO